Literature DB >> 25059209

Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma.

Peter S LaViolette1, Nikolai J Mickevicius1, Elizabeth J Cochran1, Scott D Rand1, Jennifer Connelly1, Joseph A Bovi1, Mark G Malkin1, Wade M Mueller1, Kathleen M Schmainda1.   

Abstract

BACKGROUND: Recent conflicting reports have found both brain tumor hypercellularity and necrosis in regions of restricted diffusion on MRI-derived apparent diffusion coefficient (ADC) images. This study precisely compares ADC and cell density voxel by voxel using postmortem human whole brain samples.
METHODS: Patients with meningioma were evaluated to determine a normative ADC distribution within benign fluid attenuated inversion recovery (FLAIR) T2/hyperintensity surrounding tumor. This distribution was used to calculate a minimum ADC threshold to define regions of ADC-FLAIR mismatch (AFMM), where restricted diffusion presented in conjunction with T2/FLAIR hyperintensity. Contrast-enhancing voxels were excluded from this analysis. AFMM maps were generated using imaging acquired prior to death in 7 patients with high-grade glioma who eventually donated their brains upon death. Histological samples were taken from numerous regions of abnormal FLAIR and AFMM. Each sample was computationally processed to determine cell density. Custom software was then used to downsample coregistered microscopic histology to the more coarse MRI resolution. A voxel-by-voxel evaluation comparing ADC and cellularity was then performed.
RESULTS: An ADC threshold of 0.929 × 10(-3) mm(2)/s was calculated from meningioma-induced edema and was used to define AFMM. Regions of AFMM showed significantly greater cell density in 6 of 7 high-grade glioma cases compared with regions of hyperintense FLAIR alone (P < .0001). Two patients had small regions of diffusion-restricted necrosis that had significantly lower ADC than nearby hypercellularity.
CONCLUSIONS: Regions of AFMM contain hypercellularity except for regions with extremely restricted diffusion, where necrosis is present.
© The Author(s) 2014. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ADC; FLAIR; brain tumor; diffusion; glioblastoma

Mesh:

Year:  2014        PMID: 25059209      PMCID: PMC4232087          DOI: 10.1093/neuonc/nou142

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  30 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

3.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

4.  Isolation and characterization of human malignant glioma cells from histologically normal brain.

Authors:  D L Silbergeld; M R Chicoine
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

5.  Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumour grading?

Authors:  G G Fan; Q L Deng; Z H Wu; Q Y Guo
Journal:  Br J Radiol       Date:  2006-04-26       Impact factor: 3.039

6.  Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging.

Authors:  K M Gauvain; R C McKinstry; P Mukherjee; A Perry; J J Neil; B A Kaufman; R J Hayashi
Journal:  AJR Am J Roentgenol       Date:  2001-08       Impact factor: 3.959

7.  Isolated diffusion restriction precedes the development of enhancing tumor in a subset of patients with glioblastoma.

Authors:  A Gupta; R J Young; A I Holodny; A B Lassman; S Karimi; S Sood; Z Zhang; Q Mo; P H Gutin
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-19       Impact factor: 3.825

8.  Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme.

Authors:  P C Burger; P J Dubois; S C Schold; K R Smith; G L Odom; D C Crafts; F Giangaspero
Journal:  J Neurosurg       Date:  1983-02       Impact factor: 5.115

9.  Supratentorial malignant glioma: patterns of recurrence and implications for external beam local treatment.

Authors:  L E Gaspar; B J Fisher; D R Macdonald; D V LeBer; E C Halperin; S C Schold; J G Cairncross
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

10.  Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM.

Authors:  Nikdokht Farid; Daniela B Almeida-Freitas; Nathan S White; Carrie R McDonald; Karra A Muller; Scott R Vandenberg; Santosh Kesari; Anders M Dale
Journal:  Front Oncol       Date:  2013-09-30       Impact factor: 6.244

View more
  38 in total

Review 1.  Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma.

Authors:  Mark S Shiroishi; Jerrold L Boxerman; Whitney B Pope
Journal:  Neuro Oncol       Date:  2015-09-12       Impact factor: 12.300

Review 2.  Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.

Authors:  Harpreet Hyare; Steffi Thust; Jeremy Rees
Journal:  Curr Treat Options Neurol       Date:  2017-03       Impact factor: 3.598

3.  Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma.

Authors:  H S Nguyen; N Milbach; S L Hurrell; E Cochran; J Connelly; J A Bovi; C J Schultz; W M Mueller; S D Rand; K M Schmainda; P S LaViolette
Journal:  AJNR Am J Neuroradiol       Date:  2016-08-04       Impact factor: 3.825

4.  Apparent diffusion coefficient changes predict survival after intra-arterial bevacizumab treatment in recurrent glioblastoma.

Authors:  Naveen Galla; Gloria Chiang; Shamik Chakraborty; Ranjodh Singh; A John Tsiouris; John Boockvar; Ilhami Kovanlikaya
Journal:  Neuroradiology       Date:  2017-03-25       Impact factor: 2.804

5.  Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma.

Authors:  Lei Qin; Xiang Li; Amanda Stroiney; Jinrong Qu; Jeffrey Helgager; David A Reardon; Geoffrey S Young
Journal:  Neuroradiology       Date:  2017-01-09       Impact factor: 2.804

6.  Multiparametric MRI and Coregistered Histology Identify Tumor Habitats in Breast Cancer Mouse Models.

Authors:  Bruna V Jardim-Perassi; Suning Huang; William Dominguez-Viqueira; Jan Poleszczuk; Mikalai M Budzevich; Mahmoud A Abdalah; Smitha R Pillai; Epifanio Ruiz; Marilyn M Bui; Debora A P C Zuccari; Robert J Gillies; Gary V Martinez
Journal:  Cancer Res       Date:  2019-06-11       Impact factor: 12.701

7.  Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.

Authors:  L S Hu; H Yoon; J M Eschbacher; L C Baxter; A C Dueck; A Nespodzany; K A Smith; P Nakaji; Y Xu; L Wang; J P Karis; A J Hawkins-Daarud; K W Singleton; P R Jackson; B J Anderies; B R Bendok; R S Zimmerman; C Quarles; A B Porter-Umphrey; M M Mrugala; A Sharma; J M Hoxworth; M G Sattur; N Sanai; P E Koulemberis; C Krishna; J R Mitchell; T Wu; N L Tran; K R Swanson; J Li
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-28       Impact factor: 3.825

8.  A mechanically coupled reaction-diffusion model that incorporates intra-tumoural heterogeneity to predict in vivo glioma growth.

Authors:  David A Hormuth; Jared A Weis; Stephanie L Barnes; Michael I Miga; Erin C Rericha; Vito Quaranta; Thomas E Yankeelov
Journal:  J R Soc Interface       Date:  2017-03       Impact factor: 4.118

9.  Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer.

Authors:  David A Hormuth; Jared A Weis; Stephanie L Barnes; Michael I Miga; Vito Quaranta; Thomas E Yankeelov
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-12-13       Impact factor: 7.038

10.  Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma.

Authors:  R Ceschin; B F Kurland; S R Abberbock; B M Ellingson; H Okada; R I Jakacki; I F Pollack; A Panigrahy
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.